Abstract
This report focuses on two key pharmaceutical target classes-GPCRs and Ion
Channels. GPCRs and Ion Channels are important targets. They are associated
with a number of disease areas and are currently associated with blockbuster
pharmaceutical sales status.
Identifying future direction of industry growth opportunities in these spaces
can be challenging. This report characterizes the opportunity in the GPCR and
Ion Channel spaces with respect to the following metrics:
- Technologies for interrogation
- Major Products on the market
- Vendors in the space
- Market opportunity, size, and growth (both qualitative and quantitative)
- This report draws upon a proprietary end-user survey conducted by D&MD to
assess both the qualitative and quantitative market opportunity in the GPCRs
and Ion Channels spaces. The raw data and annotations of these data are
presented in this industry report and provide a snapshot into the direction of
this market. This report also includes a SWOT analysis of the key market
participants, which serves to complement the qualitative and quantitative
analysis by offering a glimpse into the scope of opportunity in various niches.
Buy this report and:
- Identify qualitative trends-market drivers, market challenges,
bottlenecks, opportunities-in the GPCRs and Ion Channels market segments
- Examine thorough quantitative analysis: market size, market shares of the
various companies/technologies, and a cost per assay point, screening metrics
- Gain insight into growth opportunities for tools developers to develop
reagents, technologies, hardware/instrumentation to address the growth in the
GPCR and Ion Channels spaces
View Cart
